# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019364
Filing Date
2024-05-15
Accepted
2024-05-14 21:20:17
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 669381
2 |  | ex31-1.htm | EX-31.1 | 19202
3 |  | ex31-2.htm | EX-31.2 | 18925
4 |  | ex32.htm | EX-32 | 10042
| Complete submission text file | 0001493152-24-019364.txt |  | 4143423

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | envb-20240331.xsd | EX-101.SCH | 40464
6 | XBRL CALCULATION FILE | envb-20240331_cal.xml | EX-101.CAL | 51252
7 | XBRL DEFINITION FILE | envb-20240331_def.xml | EX-101.DEF | 128617
8 | XBRL LABEL FILE | envb-20240331_lab.xml | EX-101.LAB | 333114
9 | XBRL PRESENTATION FILE | envb-20240331_pre.xml | EX-101.PRE | 243503
62 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 517448

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 24946786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)